97 - 108 of 7241 results

Clinicians’ lack of obesity management knowledge may foil optimal treatment. This activity incorporates a “Man-on-the-Street” video to increase clinician awareness of patient perspectives on obesity. Evidence-based and expert recommendations on talking with patients about obesity, therapeutic options—including pharmacotherapy—and means to address obstacles in long-term management will be presented.


Clinicians’ lack of obesity management knowledge may foil optimal treatment. This activity incorporates a “Man-on-the-Street” video to increase clinician awareness of patient perspectives on obesity management. Evidence-based and expert recommendations on talking with patients about obesity and means to address obstacles in long-term management, will be presented.


This activity will provide an evidence-based approach to diagnosing irritable bowel syndrome (IBS) with minimal testing. Diagnostic tests that facilitate a positive diagnosis of IBS and effective approaches for educating patients will be highlighted. The panel will spotlight diet changes and over-the-counter agents which are helpful first-line therapies. Evidence-based guidelines will identify the most effective and best tolerated prescription agents for IBS and chronic constipation patients.



Globally, human papilloma viruses (HPV) are responsible for virtually 100% of cervical cancers, 75% of vaginal cancers, 69% of vulvar cancers, 91% of anal cancers, 63% of penile cancers, approximately 70% of oropharyngeal cancers, and almost all cases of genital warts. This activity provides an update on the prevention of HPV-related cancers and the newly expanded vaccine indications.


Until the advent of the COMPASS trial, secondary prevention in patients with peripheral artery disease consisted of either aspirin or clopidogrel monotherapy. A new era is emerging in which, by adding low-dose DOACs to low-dose aspirin, medical therapy may reduce the need for major vascular surgery or endovascular procedures. In this Virtual Expert Roundtable, the faculty will discuss the latest evidence, indications, and guideline-based utilization of dual antiplatelet therapy.


Migraine impacts approximately 1 in 7 Americans annually and accounts for between 5 and 9 million primary care office visits per year in the United States. Recently, new treatments have emerged, greatly expanding the current landscape of migraine management and bolstering the clinician’s toolbox. Join expert faculty in this Virtual Expert Roundtable as they discuss new advances in the management of migraine and answer your questions about how and when to incorporate these new therapies into treatment.

This lecture will update the primary care provider (PCP) on current treatments for diabetic retinopathy, hypertension-related eye conditions, and glaucoma. These three entities are common conditions seen in many of our patients, and a better understanding of the current treatment patterns will improve communication between primary care and ophthalmology. Increasing the specialty knowledge base of the PCPs allows for better co-management and patient education of disease process, management options, and prognosis.

Controversies around ADHD continue, and higher rates of patients are diagnosed in the U.S., raising concerns about over-diagnosis and treatment. Physicians are often placed in the middle, with the demands of patients for stimulant medications posing a challenge to good care. Conversely, there is more and more evidence for developmentally-based impairments in attention that can respond well to medication. How can we accurately diagnose and treat ADHD with these countervailing forces? A rational, data-based approach is presented including the benefits and side-effects of different approaches, including behavioral strategies. The differential diagnosis is reviewed and cautions around particular "at-risk" populations will be detailed.

Failure to prescribe anticoagulation to prevent stroke in high-risk atrial fibrillation (AF) patients is a persistent and pervasive problem. Despite a multitude of evidence-based clinical practice guidelines, and five effective oral anticoagulants for stroke prevention, at least 30% of these patients remain unprotected. This talk will focus on understanding the root causes of the failure to prevent stroke crisis. The role of antithrombotic therapy, in particular direct oral anticoagulants, will be reviewed. Strategies for implementation of best practices for stoke prevention in AF will be highlighted.

This talk will focus on several pulmonary topics that often arise in the primary care setting. I have chosen these topics based on scenarios that are common and confusing. For instance, I will review my approach to patients who come to clinic with a diagnosis of asthma for whom the clinical suspicion is low including spirometry and methacholine challenge interpretation. Next, we will review the evidence for using long term oxygen therapy in respiratory patients including the various oxygen delivery systems. I will also cover the approach to chronic cough when the typical therapies have failed to improve symptoms. I will finish with the current evidence and approach to lung cancer screening. If time remains we will answers additional questions from the audience.

This talk will review the impact of cannabis use and legalization of it in clinical practice.